GSK extends its $2.6 billion offer for Human Genome – Reuters

Buying Human Genome would give GSK full rights to these partnered drugs, underscoring the appetite among big drugmakers for biotech products to refill their medicine chests. But GSK may have more work to do in persuading investors that its $13 …